Liraglutide - A Promising Approach Against Obesity

Obesity has emerged as a global chronic condition that poses a significant public health issue. The World Health Organisation (WHO) has reported a significant increase in obesity rates, which have nearly quadrupled since 1975.1 Thus, it is crucial to consider the significant health risks associated with this issue, including the potential for developing type 2 diabetes, cardiovascular diseases, endocrinal malignancies, and musculoskeletal difficulties. Furthermore, obesity incurs substantial expenses for healthcare systems and populations at large.